Cytokines and periodontitis. Part I: Interleukin-1 and interleukin-1 receptor antagonist

Central-European Journal of Immunology

Volumn 37, Issue 2, 2012, Pages 173-177

  Słotwińska, Sylwia Małgorzata ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Host response; Interleukin 1; Interleukin 1 receptor antagonist; Periodontitis

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; ENDOTOXIN; EXOTOXIN; INTERLEUKIN 1; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

BACTERIAL VIRULENCE; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; FIBROBLAST; GENE TRANSFER; HUMAN; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; NONHUMAN; OSTEOBLAST; PERIODONTITIS; REVIEW; TISSUE REGENERATION;

EID: 84862296161     PISSN: 14263912     EISSN: 16444124     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Davies DR, Wlodawer A (1995): Cytokines and their receptor complexes. FASEB J 9: 50-56.
2. Gemmell E, Marshall RI, Seymour GJ (1997): Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontol 2000 14: 112-143. (Pubitemid 127601173)
3. Tatakis DN (1993): Interleukin-1 and bone metabolism: a review. J Periodontol 64 (5 Suppl): 416-431.
4. Rose-John S, Heinrich PC (1994): Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J 300: 281-290. (Pubitemid 24167878)
5. Arend WP (1993): Interleukin-1 receptor antagonist. Adv Immunol 54: 167-227.
6. Colotta F, Ghezzi P, Mantovani A (1998): Interleukin-1. In: Cytokines. Academic Press, San Diego, CA: 1-18.
7. Dinarello CA (1991): Interleukin-1 and interleukin-1 antagonism. Blood 77: 1627-1652.
8. Yoshimura A, Hara Y, Kaneko T, Kato I (1997): Secretion of IL-1β, TNF-α, IL-8 and IL-ra by human polymorphonuclear leukocytes in response to lipopolysaccharides from periodontopathic bacteria. J Periodont Res 32: 279-286. (Pubitemid 127521760)
9. Re F, Mengozzi M, Muzio M, et al. (1993): Expression of interleukin-1 receptor antagonist (IL-1ra) by human circulating polymorphonuclear cells. Eur J Immunol 23: 570-573. (Pubitemid 23075096)
10. Rambaldi A Torcia M, Bettoni S, et al. (1990): Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cells. Blood 76: 114-118.
11. Cominelli F, Nast CC, Clark BD, et al. (1990): Interleukin-1 gene expression, synthesis and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J Clin Invest 86: 972-980. (Pubitemid 20327390)
12. Ohlsson K, Björk P, Bergenfeldt M, et al. (1990): Interleukin-1 receptor antagonist reduced mortality from endotoxin shock. Nature 348: 550-552.
13. Boch JA, Wara-aswapati N, Auron PE (2001): Interleukin 1 signal transduction - current concepts and relevance to periodontitis. J Dent Res 80: 400-407. (Pubitemid 32378943)
14. Tsai CC, Ho YP, Chen CC (1995): Levels of interleukin-1β and interleukin-8 in gingival cervicular fluids in adults periodontitis. J Periodontol 66: 852-859.
15. Page RC (1991): The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res 26: 230-242.
16. Sims TJ, Moncla BJ, Darveau RP, Page RC (1991): Antigens of Actinobacillus actinomycetemcomitans recognized by patients with juvenile periodontitis and periodontally normal subjects. Infect Immun 59: 913-924.
17. Zambon JJ (1985): Actinobacillus actinomycetemcomitans in human periodontal disease. J Clin Periodontol 12: 1-20.
18. Granowitz EV, Clark BD, Vannier E, et al. (1992): Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes. Blood 79: 2356-2363.
19. Schytte Blix IJ, Helgeland K, Hvattum E, Lyberg T (1999): Lipopolysaccharide from Actinobacillus actinomecetemcomitans stimulates production of intrleukin-1β, tumor necrosis factor-α, interleukin-6 and interleukin-1 receptor antagonist in human whole blood. J Periodontal Res 34: 34-40.
20. Vigers GP, Caffes P, Evans RJ, et al. (1994): X-ray structure of interleukin-1 receptor antagonist at 2.0-A resolution. J Biol Chem 269: 12874-12879.
21. Fletcher J, Reddi K, Poole S, et al. (1997): Interactions between periodontopathogenic bacteria and cytokines. J Periodontal Res 32: 200-205. (Pubitemid 127521676)
22. Kabashima H, Nagata K, Hashiguchi I, et al. (1996): Interleukin-1 receptor antagonist and interleukin-4 in gingival crevicular fluid of patients with inflammatory periodontal disease. J Oral Pathol Med 25: 449-455. (Pubitemid 26420512)
23. Holmlund A, Hänström L, Lerner UH (2004): Bone resorbing activity and cytokine levels in gingival crevicular fluid before and after treatment of periodontal disease. J Clin Periodontol 31: 475-482.
24. Nishihara T, Ohsaki Y, Ueda N, et al. (1994): Mouse interleukin-1 receptor antagonist induced by Actinobacillus actinomycetemcomitans lipopolysaccharide blocks the effects of interleukin-1 on bone resorption and osteoclast-like cell formation. Infect Immun 62: 390-397. (Pubitemid 24033754)
25. Oates TW, Graves DT, Cochran DL (2002): Clinical, radiographic and biochemical assessment of IL-1/TNF-α antagonist inhibition of bone loss in experimental periodontitis. J Clin Periodontol 29: 137-143. (Pubitemid 41697746)
26. Rasmussen L, Hänström L, Lerner UH (2000): Characterization of bone resorbing activity in gingival crevicular fluid from patient with periodontitis. J Clin Periodontol 27: 41-52.
27. Delima AJ, Oates T, Assuma R, et al. (2001): Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis. J Clin Periodontol 28: 233-240. (Pubitemid 33755189)
28. Ishihara Y, Nishihara T, Kuroyanagi T, et al. (1997): Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites. J Periodontal Res 32: 524-529. (Pubitemid 127522274)
29. Rawlinson A, Dalati MH, Rahman S, et al. (2000): Inter-leukin- 1 and IL-1 receptor antagonist in gingival crevicular fluid. J Clin Periodontol 27: 738-743.
30. Rawlinson A, Grummitt JM, Walsh TF, Ian Douglas CW (2003): Interleukin 1 and receptor antagonist levels in gingival crevicular fluid in heavy smokers versus non-smokers. J Clin Periodontol 30: 42-48. (Pubitemid 38019418)
31. Waschul B, Herforth A, Stiller-Winkler R, et al. (2003): Effect of plaque, psychological stress and gender on crevicular IL-1β and IL-1 ra secretion. J Clin Periodontol 30: 238-248. (Pubitemid 38011198)
32. Słotwińska SM, Wasilewska AM, Słotwiński R, et al. (2011): The correlation between selected cytokine inhibitors and chronic periodontitis. Centr Eur J Immunol 36: 184-187.
33. Yoshinari N, Kawase H, Mitani A, et al. (2004): Effects of scaling and root planing on the amounts of interleukin-1 and interleukin-1 receptor antagonist and the mRNA expression of interleukin-1β in gingival crevicular fluid and gingival tissues. J Periodontal Res 39: 158-167. (Pubitemid 38692084)
34. Tarner IH, Fathman CG (2001): Gene therapy in autoimmune disease. Curr Opin Immunol 13: 676-682. (Pubitemid 33000161)
35. Cohen SB, Moreland LW, Cush JJ, et al. (2004): A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin-1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotreksate. Ann Rheum Dis 63: 1062-1068. (Pubitemid 39120355)
36. Clark W, Jobanputra P, Barton P, Burls A (2004): The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adult: a systematic review and economic analysis. Health Technol Assess 8: 1-105.